Patent Assignment
Reel/Frame 075442/0203
Security Agreement
Recorded: 2026-04-21
Pages: 11
Assignors
CAVION, INC.
Executed: 2026-04-13
JAZZ PHARMACEUTICALS, INC.
Executed: 2026-04-13
JAZZ PHARMACEUTICALS IRELAND LIMITED
Executed: 2026-04-13
JAZZ PHARMACEUTICALS RESEARCH UK LIMITED
Executed: 2026-04-13
JAZZ PHARMACEUTICALS THERAPEUTICS, INC.
Executed: 2026-04-13
Assignee
U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE
100 WALL STREET, SUITE 600, NEW YORK, NEW YORK, 10005
Covered Properties
(33)
Treating Essential Tremor Using (R)-2-(4-Isopropylphenyl)-N-(1-(5-(2,2,2-Trifluoroethoxy)Pyridin-2-Yl)Ethyl)Acetamide
Application:
19/184,847 →
Publication:
US US20250312323A1
7-Benzyl-4-(Methylbenzyl)-2,4,6,7,8,9-Hexahydroimidazo[1,2-A]Pyrido[3,4-E] Pyrimidin-5 (1 H)-One, Salts Thereof and Methods of Using the Same in Combination Therapy
Application:
19/079,151 →
Publication:
US US20250241920A1
Defibrotide for Use in Preventing and Treating Sepsis
Application:
19/123,601 →
Fused Bicyclic Raf Inhibitors and Methods for Use Thereof
Application:
19/205,876 →
Publication:
US US20260092063A1
Crystalline Forms of (S)-5-((3-(4-(4-Fluorophenyl)-1H-Imidazol-2-Yl)Chroman-6-Yl)Oxy)-3,4-Dihydro-1,8-Naphthyridin-2(1H)-One
Application:
19/133,462 →
Publication:
US US20260209217A1
Chiral Synthesis of Fused Bicyclic Raf Inhibitors
Application:
19/268,592 →
Publication:
US US20260049079A1
Macrocyclic Orexin Receptor Agonists and Uses Thereof
Application:
19/152,310 →
Methods of Treating Solid Tumors with Mitogen Activated Protein Kinase (Mapk) Pathway Alterations
Application:
19/156,994 →
Ghb Formulation and Method for Its Manufacture
Application:
90/015,486 →
Interferon Prodrugs
Application:
19/165,098 →
Modulators of Nanoparticle Uptake
Application:
19/471,218 →
Pyrazolo[4,3-F]Quinazoline Derivatives as Modulators of G12D Mutant Kras Useful for the Treatment of Cancer
Application:
19/483,645 →
Dosing and Administration of Recombinant L-Asparaginase
Application:
19/538,076 →
Publication:
US US20260158122A1
Gamma-Hydroxybutyrate Compositions and Their Uses for the Treatment of Disorders
Application:
19/547,596 →
Publication:
US US20260183254A1
Sodium Oxybate to Treat Idiopathic Hypersomnia
Application:
19/549,640 →
Publication:
US US20260183255A1
Gamma-Hydroxybutyrate Compositions and Their Use for the Treatment of Disorders
Application:
19/549,985 →
Publication:
US US20260191805A1
Oral Solid Dosage Forms Comprising Cannabinoids
Cannabinoids for Treating Essential Tremor in Patients
Application:
19/134,833 →
Publication:
US US20260199377A1
Cannabidiol-Type Cannabinoid Compound
Application:
19/244,951 →
Publication:
US US20250381152A1
Cannabinoids in the Treatment of Epilepsy
Application:
19/274,452 →
Publication:
US US20250345349A1
Cannabidiol-Type Cannabinoid Compound
Application:
19/279,169 →
Publication:
US US20260041698A1
Use of Cannabinoids in the Treatment of Epilepsy
Application:
19/309,408 →
Publication:
US US20250387418A1
Cannabidiol Solid Dosage Forms
Application:
19/374,982 →
Publication:
US US20260053827A1
Anticonvulsive Compounds and Uses Thereof
Application:
19/483,577 →
Method of Preparing Cannabinoids
Application:
19/432,540 →
Publication:
US US20260166448A1
Low-Intensity Treatment of Hematological Disorders
Application:
19/247,599 →
Publication:
US US20260014183A1
Liposomal Formulations of Bcl Inhibitors
Application:
19/345,495 →
Publication:
US US20260108534A1
Methods of Use of a Liposomal Composition Comprising an Atr Inhibitor
Application:
19/485,961 →
Combinations Comprising an Atr Inhibitor and a Parp Inhibitor and Methods of Use Thereof
Application:
19/485,955 →
Treating Essential Tremor Using (R)-2-(4-Isopropylphenyl)-N-(1-(5-(2,2,2-Trifluoroethoxy)Pyridin-2-Yl)Ethyl)Acetamide
Dosing and Administration of Recombinant L-Asparaginase
Use of Cannabinoids in the Treatment of Epilepsy
Method of Preparing Cannabinoids
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 23, 2021
From: LEE, MARGARET S.; PAPAPETROPOULOS, SPYRIDON; HIGGIN, MICHELLE S.; DUVVURI, MURALIKRISHNA
To: CAVION, INC.
Reel/Frame 056966/0001 →
Assignment of Assignor's Interest
Mar 19, 2025
From: STOGNIEW, MARTIN; ALLEN, JOSHUA E.
To: ONCOCEUTICS, INC.
Reel/Frame 070552/0869 →
Assignment of Assignor's Interest
Jun 24, 2025
From: CHEUNG, RONALD; FADERL, STEFAN; WANG, QI
To: CELATOR PHARMACEUTICALS, INC.
Reel/Frame 071507/0326 →
Assignment of Assignor's Interest
Jul 21, 2025
From: LEE, MARGARET SCOTT; PAPAPETROPOULOS, SPYRIDON; HIGGIN, MICHELLE S.; DUVVURI, MURALIKRISHNA
To: CAVION, INC.
Reel/Frame 071776/0261 →
Change of Name
Aug 7, 2025
From: CELATOR PHARMACEUTICALS, INC.
To: JAZZ PHARMACEUTICALS THERAPEUTICS, INC.
Reel/Frame 072341/0137 →
Assignment of Assignor's Interest
Sep 12, 2025
From: HUMPHREYS, ROBIN C.
To: JAZZ PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 072244/0789 →
Assignment of Assignor's Interest
Sep 12, 2025
From: WEREWOLF THERAPEUTICS, INC.
To: JAZZ PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 072244/0776 →
Assignment of Assignor's Interest
Sep 12, 2025
From: SALMERON-GARCIA, JOSE ANDRES; BRODKIN, HEATHER R.; ECONOMIDES, KYRIAKOS; HICKLIN, DANIEL J.
To: WEREWOLF THERAPEUTICS, INC.
Reel/Frame 072244/0768 →
Corrective Assignment to Correct the Removal of 8 Property Numbers Previously Recorded at Reel: 072341 Frame: 0137. Assignor(S) Hereby Confirms the Change of Name.
Oct 8, 2025
From: CELATOR PHARMACEUTICALS, INC.
To: JAZZ PHARMACEUTICALS THERAPEUTICS, INC.
Reel/Frame 073058/0985 →
Corrective Assignment to Correct the Remove 2 Application Numbers Previously Recorded at Reel: 07234 Frame: 0137. Assignor(S) Hereby Confirms the Change of Name.
Oct 9, 2025
From: CELATOR PHARMACEUTICALS, INC.
To: JAZZ PHARMACEUTICALS THERAPEUTICS, INC.
Reel/Frame 073133/0142 →
Confirmatory Patent Assignment
Oct 27, 2025
From: CHIMERIX, INC.; ONCOCEUTICS, INC.
To: JAZZ PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 073333/0883 →
Assignment of Assignor's Interest
Nov 11, 2025
From: WHITEHOUSE, JONATHON OLIVER; AKANDA, MD MUSHFIQ HOSSAIN; THOMAS, EDWARD; CROALL, JOHN
To: GW RESEARCH LIMITED
Reel/Frame 073567/0527 →
Change of Name
Nov 11, 2025
From: GW RESEARCH LIMITED
To: JAZZ PHARMACEUTICALS RESEARCH UK LIMITED
Reel/Frame 072861/0569 →
Assignment of Assignor's Interest
Nov 25, 2025
From: WAN, LEON; GARG, SHYAM; HAUPTSCHEIN, ROBERT; LEGROS, PHILIPPE
To: CELATOR PHARMACEUTICALS, INC.
Reel/Frame 073029/0253 →
Change of Name
Nov 25, 2025
From: CELATOR PHARMACEUTICALS, INC.
To: JAZZ PHARMACEUTICALS THERAPEUTICS, INC.
Reel/Frame 073705/0449 →
Assignment of Assignor's Interest
Nov 25, 2025
From: JAZZ PHARMACEUTICALS, INC.
To: CELATOR PHARMACEUTICALS, INC.
Reel/Frame 073029/0247 →
Assignment of Assignor's Interest
Nov 25, 2025
From: WANG, LUCY; ALLEN, CHRISTINE
To: THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO
Reel/Frame 073029/0240 →
Assignment of Assignor's Interest
Nov 25, 2025
From: WAN, LEON; GARG, SHYAM; HAUPTSCHEIN, ROBERT; LEGROS, PHILIPPE
To: JAZZ PHARMACEUTICALS, INC.
Reel/Frame 073028/0900 →
Assignment of Assignor's Interest
Dec 9, 2025
From: CHEUNG, RONALD; HUMPHREYS, ROBIN C.; MARKOVA, SVETLANA
To: JAZZ PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 073161/0082 →
Assignment of Assignor's Interest
Dec 10, 2025
From: MCCREARY, ANDREW C.; LOOMIS, SALLY; VIRLEY, DAVID
To: JAZZ PHARMACEUTICALS RESEARCH UK LIMITED
Reel/Frame 073905/0973 →
Assignment of Assignor's Interest
Dec 16, 2025
From: REDX IMMUNOLOGY LTD
To: REDX PHARMA PLC
Reel/Frame 074006/0651 →
Assignment of Assignor's Interest
Dec 16, 2025
From: JONES, CLIFFORD DAVID; COLLETTO, CHIARA
To: REDX IMMUNOLOGY LTD
Reel/Frame 074006/0635 →
Assignment of Assignor's Interest
Dec 31, 2025
From: REDX PHARMA PLC
To: JAZZ PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 073343/0027 →
Assignment of Assignor's Interest
Dec 31, 2025
From: BELFIELD, ANDREW; MARGATHE, JEAN-FRANÇOIS
To: REDX ONCOLOGY LTD
Reel/Frame 073343/0102 →
Assignment of Assignor's Interest
Dec 31, 2025
From: HAWKINS, NEIL; GLOSSOP, STEVEN CHRISTOPHER; JONES, CLIFFORD DAVID; COLLETTO, CHIARA
To: REDX IMMUNOLOGY LTD
Reel/Frame 074145/0325 →